|
WO2010065492A1
|
|
Alpha2-adrenergic agonist a calcium channel blocker composition
|
|
WO2010065489A1
|
|
Alpha2-adrenergic agonist and angiotensin ii receptor antagonist composition
|
|
WO2009002935A1
|
|
Transdermal delivery system comprising glycopyrrolate to treat sialorrhea
|
|
WO2009151457A1
|
|
Nutritional preparations
|
|
WO2008057738A1
|
|
Isoflavone-containing compositions for the treatment of osteoporosis and inflammatory joint disease
|
|
US2009093547A1
|
|
Compositions and Methods for Treating Premature Ejaculation
|
|
US2008260823A1
|
|
Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
|
|
EP1879586A1
|
|
Nutritional preparations comprising folates and essential fatty acids
|
|
US7091236B1
|
|
Method for increasing the bioavailability of glycopyrrolate
|
